Literature DB >> 32543222

Alteration of N6-methyladenosine epitranscriptome profile in unilateral ureteral obstructive nephropathy.

Xueyan Li1, Xu Fan1, Xiaoming Yin1, Huajian Liu1, Yi Yang1.   

Abstract

Aim: To reveal the alterations of N6-methyladenosine (m6A) epitranscriptome profile in kidney after unilateral ureteral obstruction in mice. Materials & methods: Total renal m6A and expressions of methyltransferases and demethylases were detected by colorimetric quantification method, real-time PCR and western blot, respectively. Methylated RNA immunoprecipitation sequencing was performed to map epitranscriptome-wide m6A profile.
Results: Total m6A levels were time-dependent decreased within 1 week, with the lowest level detected at day 7. A total of 823 differentially methylated transcripts in 507 genes were identified. Specifically, demethylated mRNAs selectively acted on multiple pathways, including TGF-β and WNT.
Conclusion: m6A modification has a functional importance in renal interstitial fibrosis during obstructive nephropathy and might be a promising therapeutic target.

Entities:  

Keywords:  N6-methyladenosine (m6A); mRNA; obstructive nephropathy; renal interstitial fibrosis; unilateral ureteral obstruction (UUO)

Year:  2020        PMID: 32543222     DOI: 10.2217/epi-2020-0126

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  4 in total

1.  Alteration of N6-methyladenosine epitranscriptome profile in lipopolysaccharide-induced mouse mesangial cells.

Authors:  Tao Liu; Xing Xing Zhuang; Xiu Juan Qin; Liang Bing Wei; Jia Rong Gao
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-02-04       Impact factor: 3.000

2.  Alteration of N6-Methyladenosine RNA Profiles in Cisplatin-Induced Acute Kidney Injury in Mice.

Authors:  Can-Ming Li; Ming Li; Wen-Bo Zhao; Zeng-Chun Ye; Hui Peng
Journal:  Front Mol Biosci       Date:  2021-07-09

3.  m6A RNA Methylation Regulators Contribute to Predict and as a Therapy Target of Pulmonary Fibrosis.

Authors:  Meng-Sheng Deng; Kui-Jun Chen; Dong-Dong Zhang; Guan-Hua Li; Chang-Mei Weng; Jian-Min Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-21       Impact factor: 2.650

4.  METTL3/N6-methyladenosine/ miR-21-5p promotes obstructive renal fibrosis by regulating inflammation through SPRY1/ERK/NF-κB pathway activation.

Authors:  Erpeng Liu; Lei Lv; Yonghao Zhan; Yuan Ma; Jinjin Feng; Yulin He; Yibo Wen; Yanping Zhang; Qingsong Pu; Fengping Ji; Xinghuan Yang; Jian Guo Wen
Journal:  J Cell Mol Med       Date:  2021-06-24       Impact factor: 5.310

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.